We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > marketing authorisation

News List

Pfizer’s Xeljanz secures marketing authorisation in Europe pharmaceutical-technology
August 06, 2018
Pfizer has received approval from the European Commission (EC) to market Xeljanz (tofacitinib citrate) for the treatment of adults suffering from severely active ulcerative colitis (UC).
EC amends marketing authorisation for Pharming’s Ruconest to include self-administration pharmaceutical-technology
January 18, 2017
The European Commission (EC) has amended the marketing authorisation for Netherlands-based Pharming Group’s Ruconest (recombinant C1 esterase inhibitor) to include self administration using the Ruconest administration kit.